Wolff Rodrigo, Díaz Luis Antonio, Norero Blanca, Urzúa Álvaro, Mezzano Gabriel, Humeres Roberto, Innocenti Franco, Castro Lorena, Pavez Claudia, Derosas Carlos, Elgueta Susana
Escuela de Medicina, Facultad de Medicina, Pontifica Universidad Católica de Chile, Santiago, Chile.
Escuela de Medicina, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Rev Med Chil. 2020 Nov;148(11):1541-1549. doi: 10.4067/S0034-98872020001101541.
In Chile, organ allocation for liver transplantation (LT) in adults is prioritized according to the MELD-Na score. Exceptions such as Hepatocellular Carcinoma (HCC) and other non-HCC exceptions receive a score called Operational MELD score.
To evaluate the effectiveness of the MELD-Na score and the operational MELD score as a prioritization system for LT in Chile.
Retrospective analysis of the waiting list (WL) of adult candidates (≥ 15 years) for elective LT in Chile from 2011 to 2017. The probability of leaving the WL, defined by death or contraindication for LT was compared in three groups: 1) Cirrhotic patients prioritized according to their real MELD-Na score (CPM), 2) HCC and 3) other non-HCC exceptions.
We analyzed 730 candidates for LT, with a median age of 57 years, 431 (56%) were men. In the study period, 352 LT were performed (48%). The annual exit rate was significantly higher in the CPM group (45.5%) compared to HCC (33.1%) and non-HCC (29.3%), (p < 0.001). Post LT survival was 86% at 1 year and 85% at 5 years, without significant differences between groups. In the CPM group, post-transplant survival was significantly lower (p < 0.05) in patients with MELD-Na ≥ 30 at transplant (81% per year) compared to patients with patients with MELD-Na < 30 (91% per year).
MELD-Na score can discriminate very well patients who have a higher risk of death in the short and medium term. However, the assignment of operational scores for situations of exception produces inequities in the allocation of organs for LT and must therefore be carefully adjusted.
在智利,成人肝移植(LT)的器官分配根据终末期肝病模型-钠(MELD-Na)评分进行优先排序。肝细胞癌(HCC)等例外情况以及其他非HCC例外情况会获得一个称为手术MELD评分的分数。
评估MELD-Na评分和手术MELD评分作为智利LT优先排序系统的有效性。
对2011年至2017年智利成人择期LT候选者(≥15岁)的等待名单(WL)进行回顾性分析。比较三组中因死亡或LT禁忌而离开WL的概率:1)根据实际MELD-Na评分优先排序的肝硬化患者(CPM),2)HCC患者,3)其他非HCC例外情况患者。
我们分析了730例LT候选者,中位年龄为57岁,431例(56%)为男性。在研究期间,进行了352例LT(48%)。CPM组的年退出率(45.5%)显著高于HCC组(33.1%)和非HCC组(29.3%),(p<0.001)。LT术后1年生存率为86%,5年生存率为85%,各组之间无显著差异。在CPM组中,移植时MELD-Na≥30的患者术后生存率(每年81%)显著低于MELD-Na<30的患者(每年91%),(p<0.05)。
MELD-Na评分能够很好地鉴别出在短期和中期有较高死亡风险的患者。然而, 为特殊情况分配手术评分会在LT器官分配中产生不公平现象,因此必须仔细调整。